Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years

The global animal antimicrobials and antibiotics market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353

However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.

The prominent players in the animal antimicrobials and antibiotics market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan), Tianjin Ringpu (China), HIPRA (Spain), Zydus Animal Health (US), China Animal Husbandry (China), and Inovet (Belgium).

ZOETIS, INC.
Zoetis accounted for the largest share of the animal antimicrobials and antibiotics market in 2020. The company provides highly diversified products for a wide range of animal species. The company’s broad geographic diversity has enabled it to deliver its animal healthcare products to more than 110 countries worldwide. To maintain its position in the animal antimicrobials and antibiotics market, the company focuses on providing innovative products, building a strong geographical network, and enhancing its R&D capabilities to deliver measurable and beneficial results for animals.

MERCK & CO.
Merck accounted for second largest of the market in 2020. The company’s strong focus on a broad range of animals, investments in collaborations & partnerships, and comprehensive quality systems and processes are driving its growth in the market. It focuses on acquisitions, expansions, and collaborations, as well as product launches. In March 2017, Merck Animal Health (known as MSD Animal Health in the US and Canada) acquired Vallée S.A., a leading privately-held producer of animal health products in Brazil. This helped Merck offer a comprehensive portfolio of products for livestock animals and expand its reach in Latin America.

ELANCO ANIMAL HEALTH
Elanco Animal Health is one of the largest players in the animal antimicrobials and antibiotics market in 2020. To remain competitive and grow, the company focuses on expanding and strengthening its partnerships with existing customers, enhancing operations and quality, enhancing capabilities and expertise, and developing innovative products. The company pursues growth through a number of organic and inorganic growth strategies, such as product launches, expansions, acquisitions, agreements, partnerships, collaborations, and divestitures, to broaden its product portfolio and grow its existing business segments. In August 2019, Elanco acquired Bayer’s Animal Health business. This acquisition doubled Elanco’s companion animal business and advanced the company’s portfolio mix by creating a balance between its food animal and companion animal segments.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=25161353

BOEHRINGER INGELHEIM
Boehringer Ingelheim was one of the leading player in the animal antimicrobials and antibiotics market in 2020. The company’s strong focus on R&D and investments in collaborations, partnerships, and acquisitions have ensured its position in the market. It focuses on expansions to strengthen its geographic footprint, presence, and growth. In August 2019, Boehringer opened a Health Management Center in China. The center integrates animal disease and health diagnostics as well as provides monitoring tools to maintain and enhance animal health.

Browse Related Reports:
Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/animal-growth-promoters-performance-enhancers-market-137134167.html